Diageo (DEO)
(Real Time Quote from BATS)
$133.40 USD
+0.50 (0.38%)
Updated Sep 17, 2024 03:54 PM ET
After-Market: $133.41 +0.01 (0.01%) 4:16 PM ET
5-Strong Sell of 5 5
D Value B Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$133.40 USD
+0.50 (0.38%)
Updated Sep 17, 2024 03:54 PM ET
After-Market: $133.41 +0.01 (0.01%) 4:16 PM ET
5-Strong Sell of 5 5
D Value B Growth B Momentum C VGM
Zacks News
What Makes Marijuana ETF the Best Performer in January?
by Sanghamitra Saha
These are the factors that led marijuana ETF to see a strong start to 2019.
Expansion & Innovation to Aid Diageo's (DEO) 1H19 Earnings
by Zacks Equity Research
Diageo (DEO) witnesses solid trends, backed by the focus on expanding geographic footprint and launching innovative products. This should continue to drive earnings in the quarters ahead.
Why Marijuana ETF is on a High in 2019
by Sweta Killa
After being beaten down in the final quarter of 2018, pot stocks staged a nice comeback this year on the renewed appeal for riskier assets.
4 Reasons Why Pot Stocks & ETF Could Be on a High in 2019
by Sanghamitra Saha
These are the factors that could send marijuana stocks and ETF high in 2019.
The Zacks Analyst Blog Highlights: Merck, Mastercard, Salesforce, Diageo and State Street
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Merck, Mastercard, Salesforce, Diageo and State Street
Top Stock Reports for Merck, Mastercard & Salesforce
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Merck (MRK), Mastercard (MA) and Salesforce (CRM).
Stock Market News For Nov 13, 2018
by Zacks Equity Research
U.S. stock markets plunged on Monday as record drop in shares of Apple and Goldman Sachs, and precipitous decline of crude oil price significantly dented investor confidence
Diageo to Offload 19 Brands to Sazerac, Can This Aid Growth?
by Zacks Equity Research
Diageo (DEO) agrees to sell its 19 brands, including Seagram's VO whiskey, to Sazerac for a total consideration of $550 million.
Marijuana ETF Enters Bear Territory: What Lies Ahead?
by Sweta Killa
Despite entering into bear territory, the cannabis ETF is up more than 24% over the past three months and the outlook remains bright.
Moving Average Crossover Alert: Diageo (DEO)
by Zacks Equity Research
Diageo plc (DEO) could be a stock to avoid from a technical perspective
Top Wall Street Stories of the Third Quarter
by Sweta Killa
We discuss some of the events that dominated the headlines in the third quarter and influenced the market.
The Zacks Analyst Blog Highlights: Diageo, Constellation Brands, Cara, Cronos and GW
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Diageo, Constellation Brands, Cara, Cronos and GW
ETFs & Stocks to Tap Marijuana Boom
by Sweta Killa
Investors seeking to tap the ongoing green rush may consider these ETFs and stocks.
The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Qualcomm, Citigroup, Diageo and Anthem
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Qualcomm, Citigroup, Diageo and Anthem
5 Best Stocks of the Top ETF of August
by Sweta Killa
Cannabis-related ETFMG Alternative Harvest ETF (MJ) is the best-performing ETF of August, gaining 22.5% and attracting $22 million in AUM.
Top Stock Reports for Bristol-Myers, Qualcomm & Citigroup
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Bristol-Myers Squibb (BMY), Qualcomm (QCOM) and Citigroup (C).
Pot Stocks Are on a High: Play These Cannabis ETFs
by Sanghamitra Saha
Beverage companies are eyeing the cannabis market aggressively for making pot-infused drinks. Play the binge with these ETFs.
Solid Organic Growth Aid Diageo's (DEO) Fiscal 2018 Earnings
by Zacks Equity Research
Diageo (DEO) delivers solid top- and bottom-line growth for the preliminary fiscal 2018, ended Jun 30, 2018, driven by strong organic sales and organic operating profit.
The Zacks Analyst Blog Highlights: BlackRock, Charter Communications, Intuitive, Statoil and Diageo
by Zacks Equity Research
The Zacks Analyst Blog Highlights: BlackRock, Charter Communications, Intuitive, Statoil and Diageo
Top Stock Reports for BlackRock, Charter Communications & Intuitive Surgical
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including BlackRock (BLK), Charter Communications (CHTR) and Intuitive Surgical (ISRG).
Zacks Market Edge Highlights: Exxon, Diageo, GlaxoSmithKline, Micron and AMN
by Zacks Equity Research
Zacks Market Edge Highlights: Exxon, Diageo, GlaxoSmithKline, Micron and AMN
What All Investors Should Know about Trade Deficits and Recessions
by Tracey Ryniec
What's the trade deficit really about? And what are the key signals that may alert investors to an upcoming recession?
U.S. Beer Opens a Can of Worms: Will Its Fizz Remain?
by Ritujay Ghosh
The tariffs certainly aren't a good sign at a time when the U.S. beer industry is already witnessing a decline in domestic beer sales due to the changing preferences of consumers.
4 Low Beta Stocks to Buy as Trade War Looks Real
by Ritujay Ghosh
Evidence of panic is spiking of the market's preferred fear gauge to its highest level since Feb 5. Build a strategy on low-risk assets and a combination of parameters that lead to better returns.
Here's Why Boston Beer (SAM) Rallies Despite a Dismal Q4
by Zacks Equity Research
While Boston Beer (SAM) fails to impress investors in the fourth quarter, its cost-saving plans and long-term innovation alongside the focus on reviving its brands keep the stock ticking.